The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative ...
Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...
Injecting a central venous line has long been a backup plan under the state's official execution policy, but it has never ...
The skin is marked to indicate the underlying target vein course, and then venous cannulation is attempted without real-time ultrasound imaging. The audio-Doppler guidance technique involves the ...
The following is a summary of “Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study,” published in the February 2025 ...
Effective January 1, 2025, the agreement grants Vizient’s members access to Teleflex’s Central Venous Access Catheters and Arterial Catheters under pre-negotiated terms, enhancing cost ...